Prof. Michael Schlierf is new B CUBE director
Meeting of B CUBE's Scientific Advisory Board in Dresden
In its second meeting on 28 September 2015 in Dresden, the Scientific Advisory Board of B CUBE discussed the previous performance of the institute and its future goals and projects. In particular, technology transfer and industrial relationships were the focus of the discussion. The board comprises seven renowned international scientists from the fields of bioprospecting, biomimetics and biophysics and two experts from industry (Novartis Pharma AG and Andor Technology Inc.). Prof. Peter Fratzl (Max Planck Institute of Colloids and Interfaces, Potsdam-Golm) acts as chair and Prof. Tanja Weil (Ulm University) as co-chair.
The mission of the Scientific Advisory Board is to provide visionary guidance for the development of the research center and to critically assess its scientific performance. Thus, the board plays an important role in strategically focusing the research directions. The members of the Scientific Advisory Board meet every two years and are in regular contact with the management of B CUBE in order to provide advise on its thematic and structural development.
Back to News Ticker